Everolimus Plus Exemestane in Postmenopausal Patients with HR+ Breast Cancer: BOLERO-2 Final Progression-Free Survival Analysis
Published Online: 2013-10-?
Journal: Advances in Therapy•Publisher: Springer Science and Business Media LLC
Authors: Ayelet Cahana•Barbara Pistilli•Bohuslav Melichar•David Lebwohl•Denise A. Yardley•Francis P. Arena•Frans Erdkamp•Gabriel N. Hortobagyi•Hope S. Rugo•Howard A. Burris•José Baselga•Katarina Petrakova•Kathleen I. Pritchard•Mario Campone•Martine Piccart•Michael Gnant•Shinzaburo Noguchi•Tetiana Taran•Wael A. Harb•Wentao Feng